Con­tract man­u­fac­tur­er Merid­i­an Med­ical Tech­nolo­gies to in­vest $100M+ in fill-fin­ish site near St. Louis

3 years ago
Manufacturing

DOJ turns to SCO­TUS ap­peal to keep abor­tion pill on the mar­ket

3 years ago
Law

Pyra­mid inks TROP2 pact with Chi­na biotech to fol­low suit of Gilead, As­traZeneca-Dai­ichi Sankyo

3 years ago
Startups
Deals

Up­dat­ed: Welling­ton puts a bow on new $476M pri­vate biotech fund

3 years ago
Financing

Tonix cuts in­ter­im analy­ses of two tri­als, halves en­roll­ment in one

3 years ago
R&D

CD­MO se­cures $31M Se­ries A to build out Ok­la­homa man­u­fac­tur­ing fa­cil­i­ty

3 years ago
Financing
Manufacturing

Up­dat­ed: New da­ta from a mas­sive Parkin­son’s tri­al could lead to break­throughs in drug de­vel­op­ment

3 years ago
R&D

Ap­peals court tem­porar­i­ly keeps abor­tion pill on the mar­ket, but FDA may have to re­vert to old­er re­stric­tions

3 years ago
FDA+
Law

Ghana ap­proves Ox­ford Uni­ver­si­ty's malar­ia vac­cine for chil­dren

3 years ago
FDA+

Trio of VCs launch­es Gael­ic-in­spired Aer Ther­a­peu­tics with $36M to prove it­self in COPD around 2025

3 years ago
Financing
Startups

In re­sponse to ouster, fired Cutera ex­ecs sue medtech com­pa­ny, hit back at board mem­bers

3 years ago
People
Law

Biotech laser-fo­cused on a sin­gle tar­get nabs $105M for fi­bro­sis, can­cer tri­als

3 years ago
Financing

Bio­phar­ma ven­ture fund­ing falls to the low­est to­tal since 2019 as star­tups pon­der al­ter­na­tive paths

3 years ago
Financing
Startups

GSK ar­gues against tak­ing Te­va 'skin­ny' la­bel suit to SCO­TUS

3 years ago
Pharma
Law

At $2M per shot, ICER says two new sick­le cell gene ther­a­pies could be cost-ef­fec­tive

3 years ago
Pharma
Cell/Gene Tx

Ahead of ad­comm, FDA backs Rex­ul­ti for first ap­proval for ag­i­ta­tion as­so­ci­at­ed with Alzheimer’s de­men­tia

3 years ago
R&D
Pharma

Out­come Health ex­ec­u­tives con­vict­ed in $1B phar­ma ad­ver­tis­ing and in­vest­ing fraud scheme

3 years ago
Pharma
Marketing

FDA may need to 'get cre­ative' if abor­tion pill ap­proval pulled this week

3 years ago
FDA+

Biotech ex­ecs say mifepri­s­tone de­ci­sion would 'u­pend' FDA's new drug ap­pli­ca­tion process

3 years ago
Pharma
FDA+

Ae­glea Bio­Ther­a­peu­tics to re­duce head­count to 10, seek strate­gic al­ter­na­tives

3 years ago
People

Amid dra­ma, Cutera toss­es out CEO and chair, ap­points re­place­ments

3 years ago
People

As­traZeneca ends dai­ly GLP-1/glucagon tri­als in switch to week­ly in­jec­tion op­tion for NASH, oth­er in­di­ca­tions

3 years ago
R&D
Pharma

Bio­gen opts in­to De­nali Alzheimer's pro­gram tar­get­ing amy­loid be­ta plaque

3 years ago
Deals

Treg play­er Gen­tiBio turns to lay­offs; Cen­tu­ry Ther­a­peu­tics CEO de­parts

3 years ago
News Briefing
First page Previous page 358359360361362363364 Next page Last page
A service from the Financial Times